M A Raskind - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

M A Raskind

Showing results (131-140 of 136) with videos related to

Pageof 14

Sort By:

You have reached the last page of results.This site can display upto 136 results.

Neurology|August 29, 2007

Statin therapy is associated with reduced neuropathologic changes of Alzheimer diseaseG Li, E B Larson, J A Sonnen, et al.

Neurology|September 1, 1996

A 1-year multicenter placebo-controlled study of acetyl-L-carnitine in patients with Alzheimer's diseaseL J Thal, A Carta, W R Clarke, et al.

Archives of Neurology|December 11, 1999

The utility of apolipoprotein E genotyping in the diagnosis of Alzheimer disease in a community-based case seriesD Tsuang, E B Larson, J Bowen, et al.

Alzheimer Disease and Associated Disorders|January 23, 1998

Clinicopathologic correlations of soluble amyloid beta-protein precursor in cerebrospinal fluid in patients with Alzheimer disease and controlsE R Peskind, J Leverenz, M R Farlow, et al.

Neuroscience|January 19, 2016

Blast exposure causes dynamic microglial/macrophage responses and microdomains of brain microvessel dysfunctionB R Huber, J S Meabon, Z S Hoffer, et al.

The Journal of Prevention of Alzheimer'S Disease|October 25, 2022

Adjudicating Mild Cognitive Impairment Due to Alzheimer's Disease as a Novel Endpoint Event in the TOMMORROW Prevention Clinical TrialL S Schneider, D A Bennett, M R Farlow, et al.

Pageof 14

Search research articles

Showing results (131-140 of 136) with videos related to

Sort By:

Pageof 14

You have reached the last page of results.This site can display upto 136 results.

Neurology|August 29, 2007

Statin therapy is associated with reduced neuropathologic changes of Alzheimer diseaseG Li, E B Larson, J A Sonnen, et al.

Neurology|September 1, 1996

A 1-year multicenter placebo-controlled study of acetyl-L-carnitine in patients with Alzheimer's diseaseL J Thal, A Carta, W R Clarke, et al.

Archives of Neurology|December 11, 1999

The utility of apolipoprotein E genotyping in the diagnosis of Alzheimer disease in a community-based case seriesD Tsuang, E B Larson, J Bowen, et al.

Alzheimer Disease and Associated Disorders|January 23, 1998

Clinicopathologic correlations of soluble amyloid beta-protein precursor in cerebrospinal fluid in patients with Alzheimer disease and controlsE R Peskind, J Leverenz, M R Farlow, et al.

Neuroscience|January 19, 2016

Blast exposure causes dynamic microglial/macrophage responses and microdomains of brain microvessel dysfunctionB R Huber, J S Meabon, Z S Hoffer, et al.

The Journal of Prevention of Alzheimer'S Disease|October 25, 2022

Adjudicating Mild Cognitive Impairment Due to Alzheimer's Disease as a Novel Endpoint Event in the TOMMORROW Prevention Clinical TrialL S Schneider, D A Bennett, M R Farlow, et al.

Pageof 14